SiriusPoint Ltd
SPNT NYSE Fire, Marine & Casualty Insurance Financials FY2016βFY2025
What SiriusPoint Ltd does
No business description yet.
- Legal name
- SiriusPoint Ltd
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 24, 2026
- Accession Β· CIK
- 0001576018-26-000032
0001576018
Revenue and margins
SiriusPoint Ltd had $3.2B of revenue in fiscal 2025, up 23.1% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 34.1% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
SiriusPoint Ltd returned $491M to shareholders in fiscal 2025. The diluted share count fell 28.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably SiriusPoint Ltd can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $1,000M | $705M | $969M | $682M | $731M |
| Debt incl. finance leases | $817M | $778M | $786M | $639M | $689M |
| Debt / equity | 0.3x | 0.4x | 0.3x | 0.3x | 0.3x |
| Total assets | $10.6B | $11.0B | $12.9B | $12.5B | $12.6B |
| Total liabilities | $8.1B | $9.0B | $10.3B | $10.6B | $10.1B |
| Shareholders' equity | $2.5B | $2.1B | $2.5B | $1.9B | $2.5B |
| Net debt (β = net cash) | β$183M | $72.7M | β$183M | β$42.9M | β$42.6M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 6 | β / 6 | β / 6 | β / 6 | 2 / 7 | 3 / 7 | 6 / 7 | 4 / 7 | 5 / 7 |
| Accruals ratio | 0.6% | 8.3% | β8.5% | 1.8% | 2.0% | 0.8% | β6.3% | β1.9% | 1.0% | 2.8% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $689M | $939M | $370M | $983M | $890M | $2.2B | $2.1B | $2.7B | $2.6B | $3.2B |
| Interest expense | $8.2M | $8.2M | $8.2M | $8.2M | $8.2M | $34.0M | $38.6M | $64.1M | $69.6M | $79.7M |
| Pretax income | $34.5M | $294M | β$321M | $201M | $152M | $45.1M | β$423M | $319M | $233M | $541M |
| Income tax | $5.6M | $12.0M | β$4.0M | $0.7M | $8.1M | β$10.7M | β$36.7M | β$45.0M | $30.7M | $81.2M |
| Net income | $27.6M | $278M | β$318M | $201M | $144M | $58.1M | β$387M | $355M | $200M | $460M |
| Net income to common | $27.5M | $278M | β$318M | $200M | $142M | $41.2M | β$403M | $315M | $176M | $443M |
| Diluted EPS | $0.26 | $2.64 | β$3.27 | $2.16 | $1.53 | $0.27 | β$2.51 | $1.85 | $1.04 | $3.64 |
| Diluted shares | 0.11B | 0.11B | 0.10B | 0.09B | 0.09B | 0.15B | 0.16B | 0.17B | 0.17B | 0.12B |
| Cash flow | ||||||||||
| Cash from operations | $4.8M | β$78.5M | $13.4M | $141M | $73.3M | $1.6M | $293M | $581M | $74.7M | $102M |
| Stock-based compensation | $8.9M | $3.6M | $5.0M | $7.0M | $6.6M | $11.4M | $30.5M | $21.4M | $20.7M | $35.9M |
| Share buybacks | $7.4M | $40.9M | $139M | $0.0M | $0.0M | $0.0M | $5.0M | $0.0M | $300M | $491M |
| Dividends paid | β | β | β | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $7.4M | $40.9M | $139M | $0.0M | $0.0M | $0.0M | $5.0M | $0.0M | $300M | $491M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $10.0M | $8.2M | $104M | $639M | $526M | $1,000M | $705M | $969M | $682M | $731M |
| Total debt | β | β | β | β | $114M | $817M | $778M | $786M | $639M | $689M |
| Goodwill | β | β | β | β | β | β | β | β | β | $0.0M |
| Intangible assets | β | β | β | β | $0.0M | $172M | $164M | $153M | $141M | $121M |
| Total assets | $3.9B | $4.7B | $3.1B | $3.4B | $3.5B | $10.6B | $11.0B | $12.9B | $12.5B | $12.6B |
| Total liabilities | $2.4B | $2.9B | $1.9B | $2.0B | $2.0B | $8.1B | $9.0B | $10.3B | $10.6B | $10.1B |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | β | β | β | β | β |
| Shareholders' equity | $1.4B | $1.7B | $1.2B | $1.4B | $1.6B | $2.5B | $2.1B | $2.5B | $1.9B | $2.5B |
| Margins | ||||||||||
| Net margin | 4.0% | 29.6% | β85.9% | 20.4% | 16.1% | 2.7% | β18.4% | 13.0% | 7.7% | 14.3% |
| Returns | ||||||||||
| Return on equity | 2.0% | 18.1% | β22.2% | 15.3% | 9.6% | 2.9% | β16.9% | 15.5% | 9.0% | 20.9% |
| Return on assets | 0.7% | 6.5% | β8.2% | 6.1% | 4.1% | 0.8% | β3.6% | 3.0% | 1.6% | 3.7% |
| Return on tangible equity | 1.9% | 16.8% | β26.4% | 14.1% | 9.1% | 1.8% | β21.1% | 13.3% | 9.8% | 18.9% |
| Growth | ||||||||||
| Revenue growth | β | 36.3% | β60.6% | 165.6% | β9.5% | 145.1% | β3.4% | 30.0% | β4.9% | 23.1% |
| Net income growth | β | 905.2% | β214.4% | β | β28.5% | β59.5% | β765.7% | β | β43.7% | 129.9% |
| EPS growth | β | 915.4% | β223.9% | β | β29.2% | β82.4% | β1,029.6% | β | β43.8% | 250.0% |
| Share count change | β | β0.3% | β7.8% | β4.5% | 0.3% | 61.5% | 6.7% | 5.9% | β0.1% | β28.2% |
| Financial health | ||||||||||
| Debt / equity | β | β | β | β | 0.1x | 0.3x | 0.4x | 0.3x | 0.3x | 0.3x |
| Capital allocation | ||||||||||
| Stock comp / revenue | 1.3% | 0.4% | 1.3% | 0.7% | 0.7% | 0.5% | 1.4% | 0.8% | 0.8% | 1.1% |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | β | β | β | 2.0 | 3.0 | 6.0 | 4.0 | 5.0 |
| Accruals ratio | 0.6% | 8.3% | β8.5% | 1.8% | 2.0% | 0.8% | β6.3% | β1.9% | 1.0% | 2.8% |
Source: SEC EDGAR XBRL filings (CIK 0001576018). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.